Table 1. Clinical profiles of study subjects.
| Clinical profile | Total | NGT | PD | T2D | P-value§ |
|---|---|---|---|---|---|
| Number of subjects (n) | 2,338 | 964 | 862 | 512 | |
| Age (yrs)* | 57.1 ± 9.0 | 55.6 ± 8.9 | 58.0 ± 8.9 | 58.3 ± 8.9† | <0.0001 |
| Sex (Male/Female) | 1,121/1,217 | 426/538 | 415/447 | 280/232 | |
| BMI (kg/m2)* | 24.6 ± 3.2 | 23.5 ± 3.0 | 25.3 ± 3.2 | 25.5 ± 3.2† | <0.0001 |
| FPG (mg/dl)* | 95.6 ± 19.3 | 83.6 ± 5.2 | 98.3 ± 9.1 | 116.4 ± 29.8† ‡ | <0.0001 |
| 2h-PG (mg/dl)* | 140.2 ± 64.3 | 92.2 ± 18.5 | 142.2 ± 31.8 | 239.1 ± 58.0† ‡ | <0.0001 |
| HbA1c (%)* | 5.7 ± 0.8 | 5.3 ± 0.3 | 5.7 ± 0.3 | 6.5 ± 1.1† ‡ | <0.0001 |
| HDL (mg/dl)* | 43.8 ± 10.2 | 45.3 ± 10.3 | 43.1 ± 9.8 | 42.1 ± 10.5† | <0.0001 |
| TCHL (mg/dl)* | 193.4 ± 36.2 | 186.6 ± 32.4 | 198.0 ± 38.9 | 198.5 ± 36.2† | <0.0001 |
| TG (mg/dl)* | 148.5 ± 118.4 | 114.3 ± 64.8 | 164.8 ± 144.6 | 185.3 ± 130.2† ‡ | <0.0001 |
*
Values are indicated as mean ± standard deviation.
§
P-values were calculated using ANOVA evaluating the significant difference amongst the three groups.
†
Values showing the difference between NGT and T2D (P<0.05).
‡
Values showing the difference between PD and T2D (P<0.05).